Nektar Therapeutics (Nasdaq: NKTR) today announced that it presented new findings from two Phase 1 clinical studies of NKTR-214, Nektar's lead immuno-oncology candidate, a CD122-biased agonist, at...

Angionetics Inc., a majority-owned subsidiary of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM), focused on the Phase 3 clinical development of Generx [Ad5FGF-4] cardiovascular...

Biotheranostics, Inc. today announced new data further demonstrating the importance of BCI in clinical practice. In a study of more than 14,000 cases, the largest patient study for BCI, BCI...

"Haitao", the term "cross border online shopping" in Chinese, it is becoming more and more popular to shop at overseas online platforms for Chinese consumers, as the increasing disposable income...

CSSi, the global leader in patient recruitment, enrollment, and retention solutions for the clinical research industry, will be exhibiting in booth #1951 at the upcoming 53rd Drug Information...

Qstream, makers of sales acceleration software that uses science, data, and mobile technology to ignite high-performing teams, announced today at the 46th LTEN Annual Conference the integration of...

ASMS 2017 – Scientists across the biopharmaceutical, clinical research and sports anti-doping industries can now simplify their insulin bioanalysis workflow using a new hybrid LC-MS consumables kit.

More than 600 people with Alpha-1 Antitrypsin Deficiency – the most common known genetic cause of chronic obstructive pulmonary disease (COPD) – along with their family members, caregivers and...

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the presentation of positive new data from multiple studies of VIBATIV® (telavancin), the...

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation DENVER, June 5, 2017 /PRNewswire/ -- MassRoots (OTCQB:...